{"id":"https://openalex.org/W2139274639","doi":"https://doi.org/10.3892/or.2013.2312","title":"Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial","display_name":"Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial","publication_year":2013,"publication_date":"2013-02-27","ids":{"openalex":"https://openalex.org/W2139274639","doi":"https://doi.org/10.3892/or.2013.2312","mag":"2139274639","pmid":"https://pubmed.ncbi.nlm.nih.gov/23446822","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3658816"},"language":"en","primary_location":{"id":"doi:10.3892/or.2013.2312","doi":"https://doi.org/10.3892/or.2013.2312","is_oa":true,"landing_page_url":"https://doi.org/10.3892/or.2013.2312","pdf_url":"http://www.spandidos-publications.com/10.3892/or.2013.2312/download","source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139274639"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.spandidos-publications.com/10.3892/or.2013.2312/download","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024576654","display_name":"Reiki Nishimura","orcid":"https://orcid.org/0000-0003-0645-7880","observed_orcids":["https://orcid.org/0000-0003-0645-7880"]},"institutions":[{"id":"https://openalex.org/I4210088918","display_name":"Kumamoto City Hospital","ror":"https://ror.org/007ge8322","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210088918"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"REIKI NISHIMURA","raw_affiliation_strings":["Department of Breast and Endocrine Surgery, Kumamoto City Hospital, Kumamoto 862-8505, Japan. nishimura.reiki@cityhosp-kumamoto.jp","Department of Breast and Endocrine Surgery, Kumamoto City Hospital, Kumamoto 862-8505, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Endocrine Surgery, Kumamoto City Hospital, Kumamoto 862-8505, Japan. nishimura.reiki@cityhosp-kumamoto.jp","institution_ids":["https://openalex.org/I4210088918"]},{"raw_affiliation_string":"Department of Breast and Endocrine Surgery, Kumamoto City Hospital, Kumamoto 862-8505, Japan","institution_ids":["https://openalex.org/I4210088918"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109275255","display_name":"Keisei Anan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124204","display_name":"Kitakyushu Municipal Medical Center","ror":"https://ror.org/0322p7317","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210124204"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"KEISEI ANAN","raw_affiliation_strings":["Department of Surgery, Kitakyushu Municipal Medical Center, Kitakyushu 802-0077, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Kitakyushu Municipal Medical Center, Kitakyushu 802-0077, Japan","institution_ids":["https://openalex.org/I4210124204"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024725726","display_name":"Yutaka Yamamoto","orcid":"https://orcid.org/0000-0001-6147-6828","observed_orcids":["https://orcid.org/0000-0001-6147-6828"]},"institutions":[{"id":"https://openalex.org/I4210122547","display_name":"Kumamoto University Hospital","ror":"https://ror.org/02vgs9327","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210122547"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"YUTAKA YAMAMOTO","raw_affiliation_strings":["Department of Breast and Endocrine Surgery, Kumamoto University Hospital, Kumamoto 860-8556, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Endocrine Surgery, Kumamoto University Hospital, Kumamoto 860-8556, Japan","institution_ids":["https://openalex.org/I4210122547"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084703606","display_name":"Kenji Higaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KENJI HIGAKI","raw_affiliation_strings":["Department of Breast Surgery, Hiroshima City Hospital, Hiroshima 730-8518, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Surgery, Hiroshima City Hospital, Hiroshima 730-8518, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034042835","display_name":"Maki Tanaka","orcid":"https://orcid.org/0000-0002-9219-0117","observed_orcids":["https://orcid.org/0000-0002-9219-0117"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MAKI TANAKA","raw_affiliation_strings":["Department of Surgery, Social Insurance Kurume Daiichi Hospital, Kurume 830\u20110013, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Social Insurance Kurume Daiichi Hospital, Kurume 830\u20110013, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008074283","display_name":"Kenji Shibuta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KENJI SHIBUTA","raw_affiliation_strings":["Department of Breast Surgery, Ueo Breast Surgical Hospital, Oita 870-0854, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Surgery, Ueo Breast Surgical Hospital, Oita 870-0854, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023097678","display_name":"Yasuaki Sagara","orcid":"https://orcid.org/0000-0001-5705-1739","observed_orcids":["https://orcid.org/0000-0001-5705-1739"]},"institutions":[{"id":"https://openalex.org/I4405282981","display_name":"Sagara Hospital","ror":"https://ror.org/00sg0ab04","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282981"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"YASUAKI SAGARA","raw_affiliation_strings":["Department of Breast/Thyroid Gland, Hakuaikai Medical Corporation, Sagara Hospital, Kagoshima 892-0833, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast/Thyroid Gland, Hakuaikai Medical Corporation, Sagara Hospital, Kagoshima 892-0833, Japan","institution_ids":["https://openalex.org/I4405282981"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056628460","display_name":"Shinji Ohno","orcid":"https://orcid.org/0000-0003-2093-3353","observed_orcids":["https://orcid.org/0000-0003-2093-3353"]},"institutions":[{"id":"https://openalex.org/I4210093709","display_name":"National Hospital Organization Kyushu Cancer Center","ror":"https://ror.org/00mce9b34","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210093709","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"SHINJI OHNO","raw_affiliation_strings":["Division of Breast Oncology, National Kyushu Cancer Center, Fukuoka 811-1395, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Breast Oncology, National Kyushu Cancer Center, Fukuoka 811-1395, Japan","institution_ids":["https://openalex.org/I4210093709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038588933","display_name":"Shigeru Tsuyuki","orcid":"https://orcid.org/0000-0003-1701-3820","observed_orcids":["https://orcid.org/0000-0003-1701-3820"]},"institutions":[{"id":"https://openalex.org/I4210151887","display_name":"Osaka Red Cross Hospital","ror":"https://ror.org/05h4q5j46","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210151887"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"SHIGERU TSUYUKI","raw_affiliation_strings":["Department of Breast and General Surgery, Osaka Red-Cross Hospital, Osaka 543-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and General Surgery, Osaka Red-Cross Hospital, Osaka 543-8555, Japan","institution_ids":["https://openalex.org/I4210151887"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091025405","display_name":"Takahiro Mase","orcid":"https://orcid.org/0009-0003-6071-550X","observed_orcids":["https://orcid.org/0009-0003-6071-550X"]},"institutions":[{"id":"https://openalex.org/I4210113086","display_name":"Ichinomiya Municipal City Hospital","ror":"https://ror.org/026a4qe69","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210113086"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"TAKAHIRO MASE","raw_affiliation_strings":["Department of Breast and Endocrine surgery, Ichinomiya Municipal Hospital, Ichinomiya 491-8558, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Endocrine surgery, Ichinomiya Municipal Hospital, Ichinomiya 491-8558, Japan","institution_ids":["https://openalex.org/I4210113086"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016215778","display_name":"Satoshi Teramukai","orcid":"https://orcid.org/0000-0003-2184-0597","observed_orcids":["https://orcid.org/0000-0003-2184-0597"]},"institutions":[{"id":"https://openalex.org/I4210150196","display_name":"Kyoto University Hospital","ror":"https://ror.org/04k6gr834","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210150196"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"SATOSHI TERAMUKAI","raw_affiliation_strings":["Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto 606-8507, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto 606-8507, Japan","institution_ids":["https://openalex.org/I4210150196"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5024576654"],"corresponding_institution_ids":["https://openalex.org/I4210088918"],"apc_list":null,"apc_paid":null,"fwci":1.5001,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":{"value":0.80461483,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"29","issue":"5","first_page":"1707","last_page":"1713"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.6801999807357788,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.6801999807357788,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.21580000221729279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.05959999933838844,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/goserelin","display_name":"goserelin","score":0.9890000224113464},{"id":"https://openalex.org/keywords/anastrozole","display_name":"anastrozole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/premenopausal-breast-cancer","display_name":"premenopausal breast cancer","score":0.8240000009536743},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.8109999895095825},{"id":"https://openalex.org/keywords/breast-cancer-recurrence","display_name":"breast cancer recurrence","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tamoxifen-resistance","display_name":"tamoxifen resistance","score":0.8130000233650208},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.7870000004768372},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.7789999842643738},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7710000276565552},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9509999752044678},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C2778043895","wikidata":"https://www.wikidata.org/wiki/Q1992653","display_name":"Goserelin","level":4,"score":0.8808143138885498},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7981829047203064},{"id":"https://openalex.org/C2776215463","wikidata":"https://www.wikidata.org/wiki/Q419143","display_name":"Anastrozole","level":5,"score":0.7892547845840454},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.6731483936309814},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6318323612213135},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6213293075561523},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5932139754295349},{"id":"https://openalex.org/C2778504769","wikidata":"https://www.wikidata.org/wiki/Q3040305","display_name":"Aromatase inhibitor","level":5,"score":0.5773873925209045},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5351985692977905},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4784676730632782},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4428877830505371},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4324757754802704},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.42451706528663635},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4014299809932709},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3527446389198303},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.31133317947387695}],"mesh":[{"descriptor_ui":"D000077384","descriptor_name":"Anastrozole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007987","descriptor_name":"Gonadotropin-Releasing Hormone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011980","descriptor_name":"Receptors, Progesterone","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011980","descriptor_name":"Receptors, Progesterone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017273","descriptor_name":"Goserelin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017273","descriptor_name":"Goserelin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017697","descriptor_name":"Premenopause","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047072","descriptor_name":"Aromatase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3892/or.2013.2312","doi":"https://doi.org/10.3892/or.2013.2312","is_oa":true,"landing_page_url":"https://doi.org/10.3892/or.2013.2312","pdf_url":"http://www.spandidos-publications.com/10.3892/or.2013.2312/download","source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2656369","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3658816","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:23446822","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23446822","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology reports","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:3658816","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3658816/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncol Rep","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3892/or.2013.2312","doi":"https://doi.org/10.3892/or.2013.2312","is_oa":true,"landing_page_url":"https://doi.org/10.3892/or.2013.2312","pdf_url":"http://www.spandidos-publications.com/10.3892/or.2013.2312/download","source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139274639.pdf","grobid_xml":"https://content.openalex.org/works/W2139274639.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W118218729","https://openalex.org/W1918073772","https://openalex.org/W1932574503","https://openalex.org/W1971927404","https://openalex.org/W1974775657","https://openalex.org/W2002196249","https://openalex.org/W2011705265","https://openalex.org/W2012194655","https://openalex.org/W2032144589","https://openalex.org/W2032207130","https://openalex.org/W2085481633","https://openalex.org/W2088094542","https://openalex.org/W2113458582","https://openalex.org/W2139248078","https://openalex.org/W2139726760","https://openalex.org/W2142534088","https://openalex.org/W2148096512","https://openalex.org/W2156610465","https://openalex.org/W2167027232","https://openalex.org/W2171458023","https://openalex.org/W2202169216"],"related_works":["https://openalex.org/W2592628511","https://openalex.org/W2269260723","https://openalex.org/W2242070674","https://openalex.org/W2171458023","https://openalex.org/W1971927404","https://openalex.org/W2377697679","https://openalex.org/W2411734679","https://openalex.org/W2012194655","https://openalex.org/W2085481633","https://openalex.org/W2032207130"],"abstract_inverted_index":{"The":[0,67,131,186],"aim":[1],"of":[2,13,165],"the":[3,9,71,140,148,193],"present":[4],"study":[5],"was":[6,70,133,142,151],"to":[7,26,28,53],"assess":[8],"efficacy":[10],"and":[11,89,94,107,124,147,204],"tolerability":[12],"a":[14,171],"luteinizing":[15],"hormone-releasing":[16],"hormone":[17,179],"(LH-RH)":[18],"analogue":[19,31,56],"plus":[20,32,57,168],"an":[21,54],"aromatase":[22],"inhibitor":[23],"following":[24],"failure":[25],"respond":[27],"standard":[29],"LH-RH":[30,55],"tamoxifen":[33],"(TAM)":[34],"in":[35,62,163,192],"premenopausal":[36,176],"patients.":[37],"Premenopausal":[38],"women":[39,177],"with":[40,64,178],"estrogen":[41],"receptor":[42,115],"(ER)-positive":[43],"and/or":[44],"progesterone-receptor":[45],"positive,":[46],"advanced":[47,183],"or":[48,182,200],"recurrent":[49,181],"breast":[50,184],"cancer":[51],"refractory":[52],"TAM":[58,197],"received":[59],"goserelin":[60],"(GOS)":[61],"conjunction":[63],"anastrozole":[65],"(ANA).":[66],"primary":[68],"endpoint":[69],"objective":[72],"response":[73],"rate":[74,87],"(ORR).":[75],"Secondary":[76],"endpoints":[77],"included":[78],"progression-free":[79],"survival":[80,83],"(PFS),":[81],"overall":[82],"(OS),":[84],"clinical":[85],"benefit":[86],"(CBR)":[88],"safety.":[90],"Between":[91],"September":[92],"2008":[93],"November":[95],"2010,":[96],"37":[97],"patients":[98,102,155],"were":[99],"enrolled.":[100],"Thirty-five":[101],"(94.6%)":[103],"had":[104,110,121,127,156],"ER-positive":[105],"tumors,":[106],"36":[108],"(97.3%)":[109,120],"human":[111],"epidermal":[112],"growth":[113],"factor":[114],"(HER)":[116],"2-negative":[117],"tumors.":[118],"Thirty-six":[119],"measurable":[122],"lesions":[123],"1":[125],"(2.7%)":[126],"only":[128],"bone":[129],"metastasis.":[130],"ORR":[132],"18.9%":[134],"[95%":[135],"confidence":[136],"interval":[137],"(CI),":[138],"8.0-35.2%],":[139],"CBR":[141],"62.2%":[143],"(95%":[144],"CI,":[145],"44.8-77.5%)":[146],"median":[149],"PFS":[150],"7.3":[152],"months.":[153],"Eight":[154],"adverse":[157],"drug":[158],"reactions":[159],"but":[160],"none":[161],"resulted":[162],"discontinuation":[164],"treatment.":[166],"GOS":[167],"ANA":[169],"is":[170,198],"safe":[172],"effective":[173],"treatment":[174,187,191],"for":[175],"receptor-positive,":[180],"cancer.":[185],"may":[188],"become":[189],"viable":[190],"future,":[194],"particularly":[195],"when":[196],"ineffective":[199],"contraindicated.":[201],"Further":[202],"studies":[203],"discussion":[205],"are":[206],"warranted.":[207]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}